Accessibility Menu
Gri Bio logo

Gri Bio

(NASDAQ) GRI

Current Price$2.00
Market Cap$3.56M
Since IPO (2023)-100%
5 Year-100%
1 Year-95%
1 Month-11%

Gri Bio Financials at a Glance

Market Cap

$3.56M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.91M

EPS (TTM)

-$79.55

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$2.00

Volume

16,425.14

Open

$2.00

Previous Close

$2.01

Daily Range

$2.00 - $2.08

52-Week Range

$1.97 - $80.36

GRI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gri Bio

Industry

Biotechnology

Employees

4

CEO

W. Marc Hertz, PhD

Headquarters

La Jolla, CA 92037, US

GRI Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-186%

Return on Capital

-1%

Return on Assets

-96%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.56M

Shares Outstanding

1.77M

Volume

16.43K

Avg. Volume

78.84K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$11.98M

EBITDA

-$11.97M

Operating Cash Flow

-$10.19M

Capital Expenditure

-$3.00K

Free Cash Flow

-$10.19M

Cash & ST Invst.

$8.23M

Total Debt

$71.00K

Gri Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.56M

N/A

Market Cap/Employee

$1.19M

N/A

Employees

3

N/A

Net Income

-$2.00M

+34.4%

EBITDA

-$2.00M

+34.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$10.99M

+246.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$58.00K

+16.0%

Return on Assets

-96.20%

N/A

Return on Invested Capital

-1.04%

N/A

Free Cash Flow

-$3.69M

-72.8%

Operating Cash Flow

-$3.69M

-112.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNSPCNS Pharmaceuticals, Inc.
$5.17-1.34%
INMInMed Pharmaceuticals Inc.
$1.63+2.52%
SILOSilo Pharma, Inc.
$5.74-6.36%
SXTP60 Degrees Pharmaceuticals, Inc.
$1.46+0.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
STISolidion Technology
$19.51+2.87%
FOXXFoxx Development
$5.46+0.91%
IBITiShares Bitcoin Trust
$35.69-0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.60+0.01%

Questions About GRI

What is the current price of Gri Bio?

Gri Bio is trading at $2.07 per share.

What is the 52-week range for Gri Bio?

Over the past 52 weeks, Gri Bio has traded between $1.97 and $80.36.

How much debt does Gri Bio have?

As of the most recent reporting period, Gri Bio reported total debt of $58.00K.

How much cash does Gri Bio have on hand?

Gri Bio reported $11.05M in cash and cash equivalents in its most recent financial results.

What is Gri Bio’s dividend yield?

Gri Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.